[video_player type=”embed” style=”1″ dimensions=”640×360″ width=”640″ height=”360″ align=”center” margin_top=”0″ margin_bottom=”20″ ipad_color=”black”]
[/video_player]
Well, Q2/2024 ended with a whimper of sorts, drifting down 0.26% in late trading. But don’t let that fool you; the S&P 500 will actually close up a healthy 5.1% for the quarter.
So don’t be distracted by the selling today – much of that is being driven by institutions engaged in quarterly rebalancing.
But, for a strong third quarter, we need to see new leadership emerge; the market cannot keep living according to the will of the tech sector alone.
As I’ve been saying, I think healthcare and biotech are more than capable of stepping up to the plate, and we’re looking for those early opportunities accordingly. While I’m at it, I wouldn’t be surprised if the ongoing bifurcation in retail continued, as well.
Let me show you what I mean – and what I’m looking for out there…
